Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome

European Journal of Endocrinology

Volumn 161, Issue 3, 2009, Pages 405-409

  Sproul, Kari ^a,b   Jones, Michelle R ^a   Azziz, Ricardo ^a,b   Goodarzi, Mark O ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANDROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE SUBUNIT ALPHA2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE SUBUNIT GAMMA3; INSULIN; PROLINE; UNCLASSIFIED DRUG; PRKAA2 PROTEIN, HUMAN; PRKAG3 PROTEIN, HUMAN; PROTEIN SUBUNIT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN VARIANT; REPRODUCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; AMP-ACTIVATED PROTEIN KINASES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN SUBUNITS; YOUNG ADULT;

EID: 70349243770     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0245     Document Type: Article

References (17)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES & Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 89 2745-2749. (Pubitemid 38766360)
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011. (Pubitemid 30644187)
3. Kahn BB, Alquier T, Carling D & Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 2005 1 15-25. (Pubitemid 43960587)
4. Horikoshi M, Hara K, Ohashi J, Miyake K, Tokunaga K, Ito C, Kasuga M, Nagai R & Kadowaki T. A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 2006 55 919-923. (Pubitemid 44100164)
5. Sun MW, Lee JY, de Bakker PI, Burtt NP, Almgren P, Rastam L, Tuomi T, Gaudet D, Daly MJ, Hirschhorn JN, Altshuler D, Groop L & Florez JC. Haplotype structures and large-scale association testing of the 50 AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 with type 2 diabetes. Diabetes 2006 55 849-855.
6. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A & Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002 51 2074-2081. (Pubitemid 34729010)
7. McAllister J. Stress signaling in the PCOS ovary. In Proceedings of the 4th Special Scientific Meeting of the Androgen Excess and PCOS Society, p 9. San Francisco, CA, 2008.
8. Zawadzki JK & Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, pp 377-384. Eds A Dunaif, JR Givens, F Haseltine & GR Merriam, Boston: Blackwell Scientific, 1992.
9. Levy JC, Matthews DR & Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192.
10. The International HapMap Consortium. The International HapMap Project. Nature 2003 426 789-796.
11. Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR & Andersson L. The 50-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. Journal of Biological Chemistry 2004 279 38441-38447. (Pubitemid 39295995)
12. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R & Vaulont S. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. Journal of Clinical Investigation 2003 111 91-98. (Pubitemid 36134852)
13. Keshavarz P, Inoue H, Nakamura N, Yoshikawa T, Tanahashi T & Itakura M. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes. Molecular Genetics and Metabolism 2008 93 200-209.
14. Spencer-Jones NJ, Ge D, Snieder H, Perks U, Swaminathan R, Spector TD, Carter ND & O'Dell SD. AMP-kinase alpha2 subunit gene PRKAA2 variants are associated with total cholesterol, lowdensity lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women. Journal of Medical Genetics 2006 43 936-942. (Pubitemid 46080191)
15. Weyrich P, Machicao F, Staiger H, Simon P, Thamer C, Machann J, Schick F, Guirguis A, Fritsche A, Stefan N & Haring HU. Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites. Diabetologia 2007 50 2097-2106. (Pubitemid 47373866)
16. Dupont J, Chabrolle C, Rame C, Tosca L & Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Research 2008 2008 1-9.
17. Diamanti-Kandarakis E, Kouli C, Alexandraki K & Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1273-1276. (Pubitemid 38368425)